Quotient BioResearch announced its launch today with the acquisition of HFL, a UK-based firm that provides research and development support to pharmaceutical and biotech companies. "HFL is the first acquisition for Quotient BioResearch and an excellent fit for our strategy of building a major presence in early stage drug development and related services," said Paul Cowan. The company is planning other acquisitions of companies involved in early-stage research work.
- here's the release on the new company